Stay updated with breaking news from Advanced Cell. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
RoslinCT to manufacture first-ever US FDA approved CRISPR-based gene therapy CASGEVY™ (exagamglogene autotemcel) RoslinCT to manufacture this grou...
RoslinCT to manufacture exagamglogene autotemcel (exa-cel) for Vertex Pharmaceuticals Inc following an extensive development collaboration RoslinCT will...
RoslinCT a leading contract development and manufacturing organization CDMO for Advanced Cell and Gene Therapies is pleased to announce the appointment of Dean J. Morris as the Chief Operations Officer at their Boston facility.
EDINBURGH, Scotland & BOSTON--(BUSINESS WIRE)--#celltherapyCDMO--RoslinCT, a leading contract development and manufacturing organization (CDMO) for Advanced Cell and Gene Therapies, is pleased to announce the appointment of Dean J. Morris as the Chief Operations Officer at their Boston facility. Mr. Morris brings a...
Gisele Deblandre, Cell-Easy's Chief Scientific Officer We're thrilled to welcome Gisele Deblandre as our new Chief Scientific Officer! TOULOUSE, France, Sept. 28, 2023 (GLOBE NEWSWIRE) -- Cell-Easy, a specialized contract development and manufacturing organization (CDMO) in cell therapy, proudly announces the appointment of Mrs. Gisele Deblandre as the Chief Scientific Officer. Over the years, Cell-Easy has recognized the challenges faced by biotechs in bridging the gap between early-stage proje